Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
Jan 03, 2012 Nature speaks with Keim about H5N1 studies Tags: h5n1, northern arizona university, paul keim, tgen north -
-
-
Jun 20, 2011 Promising skin-cancer drug nears approval Tags: daniel von hoff, scottsdale healthcare, tgen
Suntan drug greenlighted for trials
Tags: university of arizona[Source: Wired Science, Alexis Madrigal] - A drug that stimulates the body's tanning response — turning pasty skin caramel for up to two months — has been approved for human trials, but not for tanning.
Although the drug will not be available for cosmetic purposes any time soon, similar compounds are already being widely abused on the pharmaceutical black market. The official product, a man made hormone called afamelanotide, has received U.S. government approval to begin clinical trials.
"It's a bioabsorbable implant that you just inject into the skin," said Colin Mackie, director of business development for Clinuvel, the company bringing the drug to the U.S. "It stimulates melanin production."
Melanin is the body's natural pigment. It's responsible for the color of skin and protects humans from harmful solar radiation. The drug will be tested as a treatment for patients who face serious danger from the sun's rays, like those with rare genetic diseases or who must take immunosuppressants, Mackie said.
For more information click here.
Quick Links
![]()
Download a new brochure from the Flinn Foundation outlining the 2011 progress on Arizona's Bioscienced Roadmap: a record high in bioscience jobs, plus gains in firms and venture-capital funding. Numerous achievements during the year advanced the core strategies of the Roadmap.
Also, read the full Performance Assessment describing in detail Arizona's 2011 progress on key Roadmap metrics.


Share on Twitter
Share on Facebook


